3743 20 15157 3 83697 document 15157 codelists.zip application/zip ced4a152af6aa9788346efec89902da6e76701869d1fd611c9af8c86e901c097 SHA256 356694 2024-01-22 11:27:21 https://datacompass.lshtm.ac.uk/id/eprint/3743/1/codelists.zip 3743 1 1 application/zip Dataset en public cc_by_4
codelists.zip
data indefinite Codelists (Clinical Practice Research Datalink Gold, Aurum, Hospital Episode Statistics) used to define covariates and outcomes archive 475 disk0/00/00/37/43 2024-01-22 11:29:34 2025-08-21 12:44:12 2024-01-22 11:29:34 data_collection show Bidulka Patrick 0000-0001-7644-2030 TRUE 2a7d22f4f702bed30106bcd382500bbc ProjectLeader Bidulka Patrick 0000-0001-7644-2030 TRUE 2a7d22f4f702bed30106bcd382500bbc London School of Hygiene & Tropical Medicine, London, United Kingdom Codelists for: "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data" EPNC Code list antidiabetic treatments diabetes cardiovascular Codelists to define index diagnosis, comorbidities, lifestyle risk factors, co-prescriptions, and outcomes for the PERsonalised Medicine for Intensification of Treatment (PERMIT) study manuscript titled "Comparative effectiveness of alternative second-line oral antidiabetic treatments on metabolic, kidney, and cardiovascular outcomes amongst people with type 2 diabetes mellitus: a cohort study using routinely collected health data" 2024-01-18 completed London School of Hygiene & Tropical Medicine 10.17037/DATA.00003743 Dataset London School of Hygiene & Tropical Medicine, London, United Kingdom Observation Bidulka Patrick Patrick.Bidulka1@lshtm.ac.uk TRUE 2a7d22f4f702bed30106bcd382500bbc UQI RI public London, United Kingdom National Institute for Health Research (NIHR) PERsonalised Medicine for Intensification of Treatment (PERMIT) Dataset Quantitative NIHR128490 en Protocol for an observational cohort study investigating personalised medicine for intensification of treatment in people with type 2 diabetes mellitus: the PERMIT study. https://researchonline.lshtm.ac.uk/id/eprint/4662786 Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data. https://researchonline.lshtm.ac.uk/id/eprint/4672553 PERsonalised Medicine for Intensification of Treatment (PERMIT) National Institute for Health Research (NIHR) NIHR128490 http://dx.doi.org/10.13039/501100000272 2024-01-18